Polymeric Nanomaterials for Islet Targeting and Immunotherapeutic Delivery
- 23 December 2011
- journal article
- letter
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 12 (1), 203-208
- https://doi.org/10.1021/nl203334c
Abstract
Here we report a proof-of-concept for development of pancreatic islet-targeting nanoparticles for immunomodulatory therapy of autoimmune type 1 diabetes. Modified with a unique islet-homing peptide, these polymeric nanomaterials exhibit 3-fold greater binding to islet endothelial cells and a 200-fold greater anti-inflammatory effect through targeted islet endothelial cell delivery of an immunosuppressant drug. Our findings also underscore the need to carefully tailor drug loading and nanoparticle dosage to achieve maximal vascular targeting and immunosuppression.This publication has 28 references indexed in Scilit:
- Targeted Delivery of Nanoparticles to Ischemic Muscle for Imaging and Therapeutic AngiogenesisNano Letters, 2011
- Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to ApplicationsNano Letters, 2010
- Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of OnsetDiabetes, 2009
- Molecular mechanisms of endothelial hyperpermeability: implications in inflammationExpert Reviews in Molecular Medicine, 2009
- Insulitis in Type 1 Diabetes: A Sticky ProblemDiabetes, 2009
- Current advances in research and clinical applications of PLGA-based nanotechnologyExpert Review of Molecular Diagnostics, 2009
- Physical approaches to biomaterial designNature Materials, 2009
- Calcification of Multipotent Prostate Tumor EndotheliumCancer Cell, 2008
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProceedings of the National Academy of Sciences of the United States of America, 2008
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007